daunorubicin has been researched along with 1,4-dihydroxyanthraquinone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T | 1 |
| Fiallo, MM; Garnier-Suillerot, A; Kozlowski, H; Matzanke, B | 1 |
1 review(s) available for daunorubicin and 1,4-dihydroxyanthraquinone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for daunorubicin and 1,4-dihydroxyanthraquinone
| Article | Year |
|---|---|
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones | 2021 |
How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx.
Topics: Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Circular Dichroism; Daunorubicin; Doxorubicin; Humans; Hydrogen-Ion Concentration; Idarubicin; Iron; Methanol; Spectrophotometry, Ultraviolet; Sulfonic Acids; Water | 1999 |